IMMUTEP LTD-SP ADR (IMMP) Fundamental Analysis & Valuation

NASDAQ:IMMP • US45257L1089

Current stock price

0.3866 USD
+0.04 (+10.14%)
Last:

This IMMP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. IMMP Profitability Analysis

1.1 Basic Checks

  • In the past year IMMP has reported negative net income.
  • In the past year IMMP has reported a negative cash flow from operations.
  • In the past 5 years IMMP always reported negative net income.
  • IMMP had a negative operating cash flow in each of the past 5 years.
IMMP Yearly Net Income VS EBIT VS OCF VS FCFIMMP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • IMMP's Return On Assets of -57.01% is in line compared to the rest of the industry. IMMP outperforms 43.13% of its industry peers.
  • Looking at the Return On Equity, with a value of -84.85%, IMMP is in line with its industry, outperforming 48.74% of the companies in the same industry.
Industry RankSector Rank
ROA -57.01%
ROE -84.85%
ROIC N/A
ROA(3y)-29.13%
ROA(5y)-31.07%
ROE(3y)-31.51%
ROE(5y)-33.92%
ROIC(3y)N/A
ROIC(5y)N/A
IMMP Yearly ROA, ROE, ROICIMMP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • IMMP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMMP Yearly Profit, Operating, Gross MarginsIMMP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. IMMP Health Analysis

2.1 Basic Checks

  • IMMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IMMP has less shares outstanding
  • IMMP has more shares outstanding than it did 5 years ago.
  • IMMP has a worse debt/assets ratio than last year.
IMMP Yearly Shares OutstandingIMMP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
IMMP Yearly Total Debt VS Total AssetsIMMP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -4.69, we must say that IMMP is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -4.69, IMMP is not doing good in the industry: 61.70% of the companies in the same industry are doing better.
  • IMMP has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.01, IMMP is in line with its industry, outperforming 47.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -4.69
ROIC/WACCN/A
WACC9.6%
IMMP Yearly LT Debt VS Equity VS FCFIMMP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 2.97 indicates that IMMP has no problem at all paying its short term obligations.
  • The Current ratio of IMMP (2.97) is worse than 63.64% of its industry peers.
  • IMMP has a Quick Ratio of 2.97. This indicates that IMMP is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.97, IMMP is doing worse than 61.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.97
IMMP Yearly Current Assets VS Current LiabilitesIMMP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IMMP Growth Analysis

3.1 Past

  • The earnings per share for IMMP have decreased strongly by -69.70% in the last year.
  • Looking at the last year, IMMP shows a very strong growth in Revenue. The Revenue has grown by 7581.23%.
  • Measured over the past years, IMMP shows a very negative growth in Revenue. The Revenue has been decreasing by -66.35% on average per year.
EPS 1Y (TTM)-69.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)7581.23%
Revenue growth 3Y-38.18%
Revenue growth 5Y-66.35%
Sales Q2Q%6.31%

3.2 Future

  • The Earnings Per Share is expected to grow by 34.17% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, IMMP will show a very strong growth in Revenue. The Revenue will grow by 157.45% on average per year.
EPS Next Y-33.44%
EPS Next 2Y-22.08%
EPS Next 3Y4.4%
EPS Next 5Y34.17%
Revenue Next Year321.48%
Revenue Next 2Y0.78%
Revenue Next 3Y166.2%
Revenue Next 5Y157.45%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMMP Yearly Revenue VS EstimatesIMMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B
IMMP Yearly EPS VS EstimatesIMMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. IMMP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IMMP. In the last year negative earnings were reported.
  • Also next year IMMP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMMP Price Earnings VS Forward Price EarningsIMMP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMMP Per share dataIMMP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.08%
EPS Next 3Y4.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IMMP Dividend Analysis

5.1 Amount

  • IMMP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMMP Fundamentals: All Metrics, Ratios and Statistics

IMMUTEP LTD-SP ADR

NASDAQ:IMMP (4/1/2026, 2:54:56 PM)

0.3866

+0.04 (+10.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)01-29
Earnings (Next)07-29
Inst Owners39.11%
Inst Owner Change-18.27%
Ins Owners2.56%
Ins Owner ChangeN/A
Market Cap56.90M
Revenue(TTM)4.13M
Net Income(TTM)-83.92M
Analysts82
Price Target3.56 (820.85%)
Short Float %4.35%
Short Ratio3.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.83%
EPS NY rev (3m)-18.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.23%
Revenue NY rev (3m)23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.99
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.02
BVpS0.46
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -57.01%
ROE -84.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.13%
ROA(5y)-31.07%
ROE(3y)-31.51%
ROE(5y)-33.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.97
Quick Ratio 2.97
Altman-Z -4.69
F-Score3
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-33.44%
EPS Next 2Y-22.08%
EPS Next 3Y4.4%
EPS Next 5Y34.17%
Revenue 1Y (TTM)7581.23%
Revenue growth 3Y-38.18%
Revenue growth 5Y-66.35%
Sales Q2Q%6.31%
Revenue Next Year321.48%
Revenue Next 2Y0.78%
Revenue Next 3Y166.2%
Revenue Next 5Y157.45%
EBIT growth 1Y-62.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.64%
EBIT Next 3Y5.3%
EBIT Next 5Y32.52%
FCF growth 1Y-47.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.67%
OCF growth 3YN/A
OCF growth 5YN/A

IMMUTEP LTD-SP ADR / IMMP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IMMUTEP LTD-SP ADR (IMMP) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IMMP.


What is the valuation status of IMMUTEP LTD-SP ADR (IMMP) stock?

ChartMill assigns a valuation rating of 0 / 10 to IMMUTEP LTD-SP ADR (IMMP). This can be considered as Overvalued.


Can you provide the profitability details for IMMUTEP LTD-SP ADR?

IMMUTEP LTD-SP ADR (IMMP) has a profitability rating of 1 / 10.